You’re trying to decide where to put the research budget: Koyfin’s Bloomberg-style data terminal or Seeking Alpha Premium’s written research library and author ecosystem. Both will make you better informed. Neither will tell you what to buy.
They solve different halves of the same year.
This tape is a 211-point market. The S&P 500 is up +14.54% around ~7,600, but the average top-20 name is +170.4% and the average bottom-20 is −40.5%. The split inside tech is the whole story: memory, storage, and hardware printed the year; software and ad-tech gave it back. CPI sits at 3.4%. VIX is calm at ~14. CAPE is ~41–42. That split is a data problem and a thesis problem. Koyfin is built for the first. Premium is built for the second.
Seeking Alpha Premium is the better choice for most investors. At $299/year versus Koyfin’s $468/year, it gives you 5,000+ analyst articles a month, Quant ratings on 10,000+ stocks, and an author ecosystem that has been compounding since 2004. Most people get more from reading a coherent bull and bear case — then checking the factor grades — than from building another dashboard.
Koyfin wins if you already think in models. If your first move is a DCF, a comps sheet, or a 12-factor screen, the terminal is the tool. 5,900+ screening criteria and 10-year financials across 100,000+ securities are unmatched at retail.
Koyfin vs Seeking Alpha Premium: Side-by-Side
| Dimension | Koyfin | SA Premium | Edge |
|---|---|---|---|
| Core Value | Data terminal and analytics | Written research + author ecosystem | Depends on style |
| Price | $468/year (Plus; 20% off via TraderHQ) | $299/year · 7-day trial | SA Premium |
| Research Content | Data only — no analyst theses | 5,000+ articles/month from 18,000+ authors | SA Premium |
| Quant Ratings | None | Factor grades for 10,000+ stocks (daily) | SA Premium |
| Screening | 5,900+ filter criteria | 50+ metrics + Quant factor grades | Koyfin |
| Financial Data Depth | 10-year financials, estimates, segments | Basic financials, 10-year history | Koyfin |
| Global Coverage | 100K+ securities worldwide | US-focused (8–10K tickers) | Koyfin |
| Refund Policy | 30-day money-back guarantee | 7-day free trial, then non-refundable | Koyfin |
| Overall | — | — | SA Premium (for most) |
Koyfin: The Data Terminal for Self-Reliant Analysts
Koyfin was built by Rob Koyfman, a former Goldman Sachs analyst who wanted Bloomberg-level data without Bloomberg pricing. You get 10-year financials, analyst estimates, 5,900+ screening criteria, and customizable dashboards across 100,000+ global securities — at $468/year instead of $20,000+.
The customization is the product. Multi-panel dashboards that mix financials, charts, valuation metrics, and screens. Save them. Reuse them. It is the closest thing to an institutional terminal that retail pricing will buy.
It is also only a terminal. The analysis, the insight, the investment thesis — that is on you. No editorial desk. No author arguing the other side. No crowd-sourced research. You log in, pull data, build screens, and decide.
That is why the hardware/software split is a data problem on Koyfin. You can see memory manufacturers expanding capex, software operating margins compressing, and estimate revisions flipping sector by sector. The terminal will show you the split with more precision than any article. It will not tell you whether a software name down 25–60% is a broken business or a mispriced compounder. That is a sentence, not a cell.
Koyfin’s Strengths
Unmatched screening power. 5,900+ filters across fundamentals, valuations, growth, and momentum. You can build multi-factor screens most retail platforms cannot replicate.
Global coverage. 100,000+ securities across stocks, ETFs, mutual funds, government yields, currencies, commodities, and crypto. If you invest outside the US, this is a real advantage.
Data visualization. Drag-and-drop dashboards let you build a research workflow instead of borrowing someone else’s. Export-ready charts are clean enough for a client memo.
Koyfin’s Limitations
No research content. Data, not analysis. If you want a bull/bear debate before you size a position, you will not find it here.
Steep learning curve. The power is the complexity. Budget real hours before the workflow is efficient.
Higher price point. $468/year list (TraderHQ’s 20% discount brings Plus to $374). That is $169 more than Premium at list. The value is there for people who use the advanced features. It is a tax for people who will not.
Best for: Value investors, fundamental analysts, and modelers who build theses from raw data.
Explore Koyfin’s Data Platform — 20% Off via TraderHQ
Seeking Alpha Premium: Written Research and an Author Ecosystem
Seeking Alpha Premium takes the other half of the problem. Instead of a better terminal, you get a library: 18,000+ contributing analysts, 5,000+ articles a month, and a research ecosystem that has been compounding since 2004.
The Quant ratings are what keep the library from being just a blog. Every day the system scores 10,000+ US stocks across Value, Growth, Profitability, Momentum, and EPS Revisions, and assigns Strong Buy through Strong Sell. Those grades are a systematic overlay, not a curated pick list. Do not treat them like a model portfolio.
The combination is the product: read the author debate, check the Quant rating, then read the factor grades to see where the stock scores. Crowd-sourced intelligence plus a quantitative check.
That is why the hardware/software split is a thesis problem on Premium. One author will argue a software drawdown is mean-reversion. Another will argue the multiple was the product. A third will walk the earnings-call transcript and show you the capex language changing in real time. You cannot screenshot that out of a dashboard. You have to read it.
Premium is a research platform. It is not Stock Advisor. It is not Alpha Picks. It does not have a +981% or +378.5% scorecard, because it does not pick stocks.
Seeking Alpha Premium’s Strengths
Unmatched research volume. 5,000+ articles a month from 18,000+ authors covering 8,000–10,000 tickers a quarter. For any name you are considering, there are usually recent bull and bear cases. That diversity is unique at this price.
Quant ratings with factor grades. Five dimensions, daily updates, 10,000+ stocks. A systematic overlay that does not depend on any single author’s mood.
Lower barrier to entry. $299/year. 7-day free trial. Useful on day one — no dashboard configuration, just start reading.
Seeking Alpha Premium’s Limitations
Quality varies by contributor. Eighteen thousand authors means institutional-quality pieces and noise in the same feed. Filtering is a skill, not a feature.
US-focused coverage. International coverage thins fast. Koyfin’s 100K+ global book is the better data set if you leave the US.
No stock picks included. Analysis and ratings, not recommendations. If you want a tracked pick list from the same company, that is a separate Alpha Picks subscription ($449/year, no refund; +378.5% vs +105.6% since 2022, 103 positions, 70% win rate). Quant ratings are directional. They are not a portfolio.
Non-refundable after trial. Koyfin gives you 30 days. Premium gives you 7, then the year is yours. Use the trial.
Best for: Research-oriented investors who want diverse written theses and a quantitative check before they act.
Try Seeking Alpha Premium — Start with 7-Day Free Trial
Head-to-Head: The Differences That Actually Matter
Data Tools vs Research Content
This is the divide. Koyfin gives you the raw materials — financials, screens, dashboards. Premium gives you finished analysis from thousands of contributors plus a quantitative rating system.
The question is which window you open first. Koyfin users start with the numbers and build the thesis. Premium users start with the argument and use numbers to pressure-test it.
Neither is wrong. Most individual investors still get more from reading analysis than from building models. Not because modeling is inferior — it is the gold standard when you can do it — but because it takes years. Premium’s Quant ratings give you systematic rigor without requiring you to build the system.
On this tape that split is concrete. Hardware versus software is visible in Koyfin as estimate revisions, margin trends, and relative valuation. It is visible in Premium as authors arguing whether the software drawdown is a cycle or a regime. If you cannot write the second sentence, the first dashboard will not save you.
Screening: Different Philosophies
Koyfin’s screener has 5,900+ criteria. Revenue growth, free-cash-flow margins, debt-to-equity, revision trends, valuation stacks. A power tool for people who already know what they are hunting.
Premium screens through Quant factor grades. Strong Buy through Strong Sell, then Value, Growth, Profitability, Momentum, EPS Revisions. Less granular, more accessible, and the ratings carry a backtested process behind them. You are screening someone else’s model, not building yours.
Global vs US Coverage
US-only, both cover you. International, the gap is large: Koyfin’s 100,000+ global securities versus Premium’s US-heavy contributor model and Quant universe. For a global book, that can be the whole decision.
The Price and Risk Comparison
Premium is $299/year. Koyfin is $468/year. That is $169 a year in Premium’s favor at list — or about $75 if you take the TraderHQ 20% off on Koyfin Plus.
The refund policies run the other way. Koyfin: 30-day money-back. Premium: 7-day trial, then non-refundable. Cheaper is not always lower-risk.
How to Decide
Choose Koyfin if:
- You build theses from financial statements and raw data
- You want 5,900+ screening criteria for complex multi-factor screens
- You invest globally and need coverage beyond US markets
- You prefer building your own analysis over reading other people’s
Choose Seeking Alpha Premium if:
- You want to read expert analysis before you form a view
- Quant ratings and factor grades fit how you research
- You are US-focused and want the broadest author coverage available
- You want a lower price and something useful on day one
Use both if:
- You want Koyfin’s data depth for screens and Premium’s authors and Quant ratings for validation
- Your process is model first, article second — or the reverse
- You can put roughly $770/year ($299 + $468) toward the research stack
The tiebreaker: Think about the last stock you actually researched. Did you open a financial data platform or a research article first? The tool you reach for instinctively is the one you should pay for. The hardware/software year does not change that. It just makes the cost of picking the wrong half more obvious.
Start with Seeking Alpha Premium — 7-Day Free Trial
The Bottom Line
Seeking Alpha Premium wins for most investors. Eighteen thousand author perspectives, Quant ratings as a systematic overlay, and $299/year deliver more actionable research than most people will extract from a terminal. If you want to be better informed before you commit capital, the library and the rating system are the edge.
Koyfin is indispensable for fundamental analysts. If you evaluate companies through models, comps, and complex screens — and you can turn a 10-year financial into a thesis — 5,900+ criteria and Bloomberg-level data depth are unmatched at retail. No amount of crowd-sourced opinion replaces your own work when you know how to do it.
These platforms are more complementary than competitive. Premium tells you what other serious investors think. Koyfin gives you the data to decide if they are right. In a 211-point market with the index up +14.54% and CAPE at ~41–42, the investors who outperform are the ones who research all the way through — whether that means reading more analysis or building a better model.
Get Started with Seeking Alpha Premium
Frequently Asked Questions
Koyfin vs Seeking Alpha Premium: which is better?
Seeking Alpha Premium is better for most investors because 18,000+ analyst articles, Quant ratings on 10,000+ stocks, and a $299/year price (versus Koyfin’s $468/year) provide more immediately useful research. Koyfin is the better choice for fundamental analysts who build their own models and need Bloomberg-level data tools, 5,900+ screening criteria, and global coverage of 100,000+ securities. The 2026 hardware/software split is a data problem on Koyfin and a thesis problem on Premium — most investors are short a thesis, not a terminal.
Is Koyfin worth it?
Yes, for investors who do their own fundamental analysis. Koyfin delivers institutional-grade financial data — 10-year financials, analyst estimates, and 5,900+ screening criteria — at $468/year (20% off via TraderHQ on the Plus tier), versus Bloomberg at $20,000+. The learning curve is steep. Casual researchers will not extract the value. Serious analysts who build screens and models will. Past platform adoption does not guarantee it will meet every investor’s needs.
Is Seeking Alpha Premium worth it?
Yes, for research-oriented investors. At $299/year with a 7-day trial, Premium provides 5,000+ analyst articles a month, Quant ratings, and coverage of 8,000–10,000 tickers a quarter. The value is research breadth and systematic ratings, not stock picks — those require a separate Alpha Picks subscription ($449/year, no refund). Quality varies by contributor. You will need judgment. The trial is short. Use it.
Can I use both Koyfin and Seeking Alpha Premium?
Yes, and they complement each other. Koyfin is the raw financial data and the screener. Premium is the author debate and the Quant overlay. Together they run about $767/year at list — less than many single-service professional terminals. Screen and model in Koyfin. Then read the Premium theses and factor grades before you commit capital. That is a research stack, not a redundancy.
Does Seeking Alpha Premium give stock picks?
No. Seeking Alpha Premium provides analyst articles and Quant ratings, not a curated pick list. Quant ratings run Strong Buy through Strong Sell across 10,000+ stocks. That is a systematic score, not a portfolio. For tracked recommendations from Seeking Alpha, you need the separate Alpha Picks subscription at $449/year (no refund; +378.5% vs +105.6%, 103 positions, 70% win rate). Premium is a research platform. Alpha Picks is the picks service. Do not assign either book’s returns to Premium.